Amanote Research
Register
Sign In
409. Therapeutic Efficacy of Oncolytic Herpes Virus and Chemotherapy for Treatment of Late-Stage Ovarian Cancer
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34744-x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer
Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 With Integrin Β1 Blocking Antibody OS2966
Molecular Cancer Therapeutics
Cancer Research
Oncology
Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer
Clinical Cancer Research
Cancer Research
Oncology
A Potent Oncolytic Herpes Simplex Virus for the Therapy of Advanced Prostate Cancer
Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic
Cancer Research
Cancer Research
Oncology
Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta
Cancer Cell International
Cancer Research
Oncology
Genetics
Comparison of Safety, Delivery, and Efficacy of Two Oncolytic Herpes Viruses (G207 and NV1020) for Peritoneal Cancer
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
